ORIGINAL RESEARCH article
Front. Med.
Sec. Pulmonary Medicine
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1681411
Burden of Chronic Obstructive Pulmonary Disease (COPD) in Ghana and Globally from 1990 to 2021, with Projections through 2050: A Systematic Analysis Based on the Global Burden of Disease Study 2021
Provisionally accepted- 1Wannan Medical College, Wuhu, China
- 2Takoradi Hospital, P.O. Box 7 Takoradi, Ghana, Tel: +233-031-2022501/2, Takoradi, Ghana
- 3Bengbu Medical University, Bengbu, China
- 4Yijishan Hospital of Wannan Medical College, Wuhu, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: To assess the burden of chronic obstructive pulmonary disease (COPD) in Ghana within a global context, analyze temporal trends and risk factor attribution from 1990 to 2021, and project the future burden through 2050. Study Design: Secondary analysis of Global Burden of Disease (GBD) 2021 data, using statistical modeling to evaluate trends in COPD prevalence, incidence, mortality, disability-adjusted life years (DALYs), and attributable risk factors. Future projections were generated using Bayesian Age-Period-Cohort (BAPC) modeling. Data Source: GBD 2021 study, providing standardized estimates for 369 diseases across 204 countries and territories. Main Outcome Measures: COPD-related deaths, prevalence, incidence, DALYs, age-standardized rates (ASRs), risk factor attribution, percentage change, age-specific death rates, and projections to 2050. Results: From 1990 to 2021, Ghana experienced a 157% increase in COPD deaths (from 693 to 1,782), compared to a 49% global increase. Ghana's age-standardized death rate (ASDR) declined by only 7%, far below the global reduction of 37%. COPD prevalence in Ghana tripled, rising from 0.1 to 0.3 million, while incidence increased by 215% and DALYs by 171%. Globally, DALYs rose by 40% over the same period. In Ghana, household air pollution from solid fuel use accounted for 40% of COPD deaths, followed by ambient air pollution (25%). Globally, particulate matter pollution (41%) and smoking (36%) were dominant. Projections show continued increases in prevalence and incidence, particularly among adults aged 40-64, with plateauing DALYs and declining ASDR by the 2040s. Mortality increases sharply after age 60, with higher burden among males. Cohort analysis reveals rising mortality risk among those born after 1960. Conclusion: Despite modest ASDR reductions, Ghana's absolute COPD burden is increasing, driven by preventable risk factors such as household air pollution. These findings highlight the need for targeted interventions, including clean cook-stove programs, improved air quality monitoring, and expanded access to spirometry and early screening. Such efforts are essential to reduce COPD-related morbidity and mortality and advance Sustainable Development Goal 3.4.
Keywords: chronic obstructive pulmonary disease, burden of disease, Epidemiology, Ghana, Africa, Risk factors, Global burden of disease, COPD
Received: 07 Aug 2025; Accepted: 13 Oct 2025.
Copyright: © 2025 Mensah, Liu, Pan, Lu, Zhou, Zhang, Cheng, Wei and Zha. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yusheng Cheng, chengys1222@126.com
Shuoshuo Wei, weishuoshuo@yjsyy.com
Lei Yusheng Zha, zhalei@yjsyy.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.